Search

Militza Ausmanas Phones & Addresses

  • Port Angeles, WA
  • Sequim, WA
  • Olympia, WA
  • Annandale, NJ
  • Stuart, VA
  • Montoursville, PA
  • Williamsport, PA
  • Fern Park, FL
  • Brentwood, TN
  • Wayne, PA

Work

Company: Olympia Family/Internal Med Address: 3920 Capital Mall Dr Sw Suite 200, Olympia, WA 98502 Phones: (360) 596-4899

Education

School / High School: Meharry Medical College 2006

Languages

English

Awards

Healthgrades Honor Roll

Ranks

Certificate: Family Practice, 2010

Specialities

Family Medicine

Professional Records

Medicine Doctors

Militza Ausmanas Photo 1

Dr. Militza Ausmanas, Olympia WA - MD (Doctor of Medicine)

View page
Specialties:
Family Medicine
Age:
48
Address:
Olympia Family/Internal Med
3920 Capital Mall Dr Sw Suite 200, Olympia, WA 98502
(360) 596-4899 (Phone)
Certifications:
Family Practice, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Meharry Medical College
Graduated: 2006
Medical School
Williamsport Hospital and Medical Center
Graduated: 2006
Militza Ausmanas Photo 2

Militza Ausmanas

View page
Specialties:
Family Medicine
Work:
Olympia Family MedicineOlympia Family/Internal Medicine
3920 Capital Mall Dr SW STE 200, Olympia, WA 98502
(360) 596-4899 (phone), (360) 596-4889 (fax)
Education:
Medical School
Meharry Medical College School of Medicine
Graduated: 2007
Procedures:
Arthrocentesis
Vaccine Administration
Conditions:
Acute Sinusitis
Allergic Rhinitis
Anemia
Constipation
Contact Dermatitis
Languages:
English
Description:
Dr. Ausmanas graduated from the Meharry Medical College School of Medicine in 2007. She works in Olympia, WA and specializes in Family Medicine. Dr. Ausmanas is affiliated with Capital Medical Center.

Business Records

Name / Title
Company / Classification
Phones & Addresses
Militza Ausmanas
General Medical Practice
Olympia Family Medicine Inc
Medical Practice · Medical Doctor's Office · Emergency Medicine · Family Doctor · Offices of Physicians (except Mental Health Specialists)
3622 Ensign Rd NE #A, Olympia, WA 98506
3920 Capitol Mall Dr SW, Olympia, WA 98502
3920 Capital Mall Dr SW STE 200, Olympia, WA 98502
(360) 596-4899, (360) 459-7282
Militza Ausmanas
Family Practitioner
Nicholas T Kipreos MD LLC
Medical Doctor's Office
797 Woodland Dr, Stuart, VA 24171
PO Box 912, Stuart, VA 24171
835 Woodland Dr STE 200, Stuart, VA 24171
(276) 694-6677

Publications

Us Patents

Low Dose Estrogen Interrupted Hormone Replacement Therapy

View page
US Patent:
7078394, Jul 18, 2006
Filed:
Mar 22, 2004
Appl. No.:
10/806613
Inventors:
Robert F. Casper - Toronto, CA
Gary A. Shangold - Califon NJ, US
Militza K. Ausmanas - Lake Forest IL, US
Assignee:
Duramed Pharmaceuticals, Inc. - Pomona NY
International Classification:
A61K 31/56
US Classification:
514170
Abstract:
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 μg per day of norgestimate.

Low Dose Estrogen Interrupted Hormone Replacement Therapy

View page
US Patent:
7320970, Jan 22, 2008
Filed:
May 24, 2006
Appl. No.:
11/439171
Inventors:
Robert F. Casper - Toronto, CA
Gary A. Shangold - Califon NJ, US
Militza K. Ausmanas - Lake Forest IL, US
Assignee:
Duramed Pharmaceutials, Inc. - Cincinnati OH
Jencap Research Ltd. - Toronto, Ontario
International Classification:
A61K 31/56
US Classification:
514170
Abstract:
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 μg per day of norgestimate.

Low Dose Estrogen Interrupted Hormone Replacement Therapy

View page
US Patent:
20020165209, Nov 7, 2002
Filed:
Apr 30, 2002
Appl. No.:
10/134455
Inventors:
Robert Casper - Toronto, CA
Gary Shangold - Califon NJ, US
Militza Ausmanas - Lake Forest IL, US
Assignee:
Jencap Research Ltd.
International Classification:
A61K031/56
US Classification:
514/169000
Abstract:
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 g per day of norgestimate.

Low Dose Estrogen Interrupted Hormone Replacement Therapy

View page
US Patent:
20080182828, Jul 31, 2008
Filed:
Nov 27, 2007
Appl. No.:
11/945986
Inventors:
Robert F. CASPER - Toronto, CA
Gary A. SHANGOLD - Califon NJ, US
Militza K. AUSMANAS - Lake Forest IL, US
Assignee:
Duramed Pharmaceuticals, Inc. - Cincinnati OH
Jencap Research Ltd. - Toronto
International Classification:
A61K 31/565
A61P 19/10
A61P 9/00
A61P 25/28
US Classification:
514170
Abstract:
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 μg per day of norgestimate.

Low Dose Estrogen Interrupted Hormone Replacement Therapy

View page
US Patent:
20100063019, Mar 11, 2010
Filed:
Sep 8, 2009
Appl. No.:
12/555196
Inventors:
Robert F. CASPER - Toronto, CA
Gary A. SHANGOLD - Califon NJ, US
Militza K. AUSMANAS - Lake Forest IL, US
Assignee:
Duramed Pharmaceuticals, Inc. - Cincinnati OH
Jencap Research Ltd. - Toronto
International Classification:
A61K 31/56
A61P 5/24
US Classification:
514182
Abstract:
A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17β-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 μg per day of norgestimate.
Militza K Ausmanas from Port Angeles, WA, age ~48 Get Report